Raheela Ashfaq, MD, FCAP
Head, Breast Pathology
2007–2009 Professor, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center
2002–2009 Professor, Department of Pathology, University of Texas Southwestern Medical Center
1998–2002 Associate Professor, Department of Pathology, University of Texas Southwestern Medical Center
1993–1998 Assistant Professor, Department of Pathology, University of Texas Southwestern Medical Center
1992–1993 Instructor, Department of Pathology, University of Texas Southwestern Medical Center
1991–1992 Fellow in Surgical Pathology, University of Texas Southwestern Medical Center
1989–1991 Resident in Pathology, University of Texas Southwestern Medical Center
1987–1989 Resident in Pathology, University of Texas, Medical Branch, Galveston
2008 MS, Medical Management, University of Texas, Dallas
1982 MB, BS, Fatima Jinnah Medical College, Pakistan
1976 FSc, Government College, Rawalpindi, Pakistan
Certification in Cytopathology
Diplomate, American Board of Pathology, Anatomic and Clinical Pathology
Association of Molecular Pathology
American Society of Clinical Oncology
American Association of Cancer Research
College of American Pathologists
United States and Canadian Academy of Pathologists
American Society of Cytopathology
American Society of Clinical Pathology
Ashfaq R. Molecular profiling for personalized cancer care. Clin Exp Metastasis. 2012 Oct;29(7):653–5.
Uhr JW, Huebschman ML, Frenkel EP, Lane NL, Ashfaq R, Liu H, Rana DR, Cheng L, Lin AT, Hughes GA, Zhang XJ, Garner HR. Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. Transl Res. 2012 May; 159(5):366–75.
Siddiqui MT, Zakowski MF, Ashfaq R, Ali SZ. Breast masses in males: multi-institutional experience on fine-needle aspiration. Diagn Cytopathol. 2002 Feb; 26(2):87–91.
Wang S, Hossein Saboorian M, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, Hynan L, Ashfaq R. Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status. Mod Pathol. 2002 Feb; 15(2):137–45.
Arun B, Kilic G, Yen C, Foster B, Yardley D, Gaynor R, Ashfaq R. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Cancer. 2003 Dec 15; 98(12):2554–9.
Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LW, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J. HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA. 2004 Jun 22; 101(25):9393–8.
Sharma S, Saboorian HM, Frawley WH, Frenkel EP, Haley BB, Ashfaq R. MIB1 labeling index as an indicator of chemoresponse in carcinoma of the breast. Appl Immunohistochem Mol Morphol. 2004 Dec; 12(4):290–5.
Ferguson DA, Muenster MR, Zang Q, Spencer JA, Schageman JJ, Lian Y, Garner HR, Gaynor RB, Huff JW, PertsemlidisA, Ashfaq R, Schorge J, Becerra C, Williams NS, Graff JM. Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trap. Cancer Res. 2005 Sep 15; 65(18):8209–17.
Lewis CM, Herbert BS, Bu D, Halloway S, Beck A, ShadeoA, Zhang C, Ashfaq R, Shay JW, Euhus DM. Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier. Breast Cancer Res Treat. 2006 Sep; 99(1):103–15.
Coyle YM, Xie XJ, Hardy DB, Ashfaq R, Mendelson CR. Progesterone receptor expression is a marker for early stage breast cancer: implications for progesterone receptor as a therapeutic tool and target. Cancer Lett. 2007 Dec 18; 258(2):253–61.